Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Cash from Investing Activities (2020 - 2025)

GeneDx Holdings has reported Cash from Investing Activities over the past 6 years, most recently at -$11.1 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$11.1 million for Q4 2025, down 2033.33% from a year ago — trailing twelve months through Dec 2025 was -$61.5 million (down 104.16% YoY), and the annual figure for FY2025 was -$61.5 million, down 104.16%.
  • Cash from Investing Activities for Q4 2025 was -$11.1 million at GeneDx Holdings, down from -$4.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for WGSWW hit a ceiling of $843000.0 in Q1 2024 and a floor of -$130.3 million in Q2 2022.
  • Median Cash from Investing Activities over the past 5 years was -$4.9 million (2021), compared with a mean of -$14.9 million.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 2807.77% in 2022 and later skyrocketed 282.47% in 2024.
  • GeneDx Holdings' Cash from Investing Activities stood at -$7.7 million in 2021, then skyrocketed by 63.11% to -$2.8 million in 2022, then plummeted by 71.39% to -$4.9 million in 2023, then surged by 89.33% to -$519000.0 in 2024, then tumbled by 2033.33% to -$11.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$11.1 million (Q4 2025), -$4.7 million (Q3 2025), and -$36.4 million (Q2 2025) per Business Quant data.